| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |